Shares of Cryoport Inc. (CYRX) are down over 50% from their 52-week high of $14.21, recorded last May, to trade around $7.
The company is a global provider of temperature-controlled supply chain solutions for the life sciences sector, with a strong focus on regenerative medicine. It provides a full range of services and products to help biopharmaceutical companies, CDMOs, CROs, researchers, and drug developers manage the complex logistics of cell and gene therapies. By ensuring safe, reliable transport and storage, the company plays a key role in reducing risk and supporting the success of clinical trials and commercial launches worldwide. As of March 31, 2025, the company was supporting 711 clinical trials, including 79 in Phase 3, and 19 approved commercial therapies around the globe.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.